Health: new vaccines approved to protect birds and pigs in Argentina

Published Dec 9, 2024

Tridge summary

Two new vaccines have been approved in Argentina for pigs to protect against Porcine Circovirus type 2a and 2b, and Mycoplasma hyopneumoniae, and a vaccine for chickens to guard against Marek's disease, infectious bursal disease, and Newcastle disease. These vaccines are crucial for preventing growth retardation and death in pigs, and immune response in chickens. The vaccines underwent authorization by the Undersecretariat of Agricultural and Forestry Production, the Coordination of Innovation and Biotechnology, and the National Advisory Commission on Agricultural Biotechnology, with compliance required to SENASA regulations before commercialization.
Disclaimer:The above summary was generated by Tridge's proprietary AI model for informational purposes.

Original content

These are two new vaccines against Porcine Circovirus type 2a and type 2b and respiratory disease due to Mycoplasma hyopneumoniae and a third that protects chickens against Marek's disease (MD), infectious bursal disease (Gumboro disease) and Newcastle disease (ND). Vaccines aimed at the pig sector represent a great protection for the productive sector since respiratory disease caused by Mycoplasma hyopneumoniae and porcine circovirus type 2 cause growth retardation. In the second case, death during the first months of the pig's life. The avian vaccine is based on genetically modified herpesvirus (from turkey), which acts by inoculating chickens in ovo or at day of age in order to produce an immune response for the three diseases mentioned. The respective authorizations were made through the Undersecretariat of Agricultural and Forestry Production, after the intervention of the Coordination of Innovation and Biotechnology and the National Advisory Commission on Agricultural ...
Source: Agromeat

Would you like more in-depth insights?

Gain access to detailed market analysis tailored to your business needs.
By clicking “Accept Cookies,” I agree to provide cookies for statistical and personalized preference purposes. To learn more about our cookies, please read our Privacy Policy.